The Carcinogenicity of r-Propiolactone for Mouse-Skin
1956

The Carcinogenicity of Beta-Propiolactone for Mouse Skin

Sample size: 32 publication Evidence: moderate

Author Information

Author(s): F. J. C. Roe, O. M. Glendenning

Primary Institution: Cancer Research Department, London Hospital Medical College

Hypothesis

Is beta-propiolactone carcinogenic for mouse skin?

Conclusion

Beta-propiolactone is carcinogenic for mouse skin, with tumors appearing after repeated applications.

Supporting Evidence

  • Papillomata began to appear after 27 applications of beta-propiolactone.
  • Three tumors appeared alongside a scar after high concentrations of beta-propiolactone were applied.
  • Single intravenous injections of beta-propiolactone did not increase lung tumor incidence.

Takeaway

This study found that a chemical called beta-propiolactone can cause skin tumors in mice, especially when applied repeatedly.

Methodology

Mice were treated with beta-propiolactone and croton oil, and their skin was examined for tumor formation.

Limitations

The study did not explore the long-term effects beyond 30 weeks for some mice.

Participant Demographics

Male and female stock albino mice of the 'S' strain were used.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication